Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Y Look

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Oncology|December 10, 1997
A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyR Asbury, J A Blessing, K Y Look, et al.
Anticancer Research|April 13, 2001
Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinomaA Demeter, M Abonyi, K Y Look, et al.
American Journal of Obstetrics and Gynecology|March 1, 1993
Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, W P McGuire, et al.
American Journal of Clinical Oncology|February 1, 1996
A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group StudyK Y Look, J A Blessing, M D Adelson, et al.
American Journal of Clinical Oncology|April 1, 1996
A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group StudyJ H Malfetano, J A Blessing, H D Homesley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancerT S Barlow, M Przybylski, J M Schilder, et al.
Gynecologic Oncology|April 1, 1997
Collagenase expression in ovarian cancer cell linesD H Moore, B Allison, K Y Look, et al.
Life Sciences|January 1, 1994
Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cellsR L Singhal, Y A Yeh, K Y Look, et al.
American Journal of Obstetrics and Gynecology|June 1, 1991
Trends in the operative management of invasive squamous carcinoma of the vulva at Indiana University, 1974 to 1988G P Sutton, M R Miser, F B Stehman, et al.
American Journal of Clinical Oncology|December 1, 1992
5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology GroupK Y Look, J A Blessing, H B Muss, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Oncology|December 10, 1997
A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyR Asbury, J A Blessing, K Y Look, et al.
Anticancer Research|April 13, 2001
Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinomaA Demeter, M Abonyi, K Y Look, et al.
American Journal of Obstetrics and Gynecology|March 1, 1993
Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, W P McGuire, et al.
American Journal of Clinical Oncology|February 1, 1996
A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group StudyK Y Look, J A Blessing, M D Adelson, et al.
American Journal of Clinical Oncology|April 1, 1996
A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group StudyJ H Malfetano, J A Blessing, H D Homesley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancerT S Barlow, M Przybylski, J M Schilder, et al.
Gynecologic Oncology|April 1, 1997
Collagenase expression in ovarian cancer cell linesD H Moore, B Allison, K Y Look, et al.
Life Sciences|January 1, 1994
Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cellsR L Singhal, Y A Yeh, K Y Look, et al.
American Journal of Obstetrics and Gynecology|June 1, 1991
Trends in the operative management of invasive squamous carcinoma of the vulva at Indiana University, 1974 to 1988G P Sutton, M R Miser, F B Stehman, et al.
American Journal of Clinical Oncology|December 1, 1992
5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology GroupK Y Look, J A Blessing, H B Muss, et al.
Pageof 6